Department of Pathology Microbiology and Immunology
-
June 12, 2024
Obesity-cancer connection discovery suggests strategies for improving immunotherapy
The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy. -
May 28, 2024
Jennifer Gordetsky honored for her history of urology research
Jennifer Gordetsky, MD, believes the most important part of medical history is making sure our mistakes are not forgotten -
April 22, 2024
Study reveals potential new way to stop a common kidney cancer
Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it. -
April 15, 2024
Mariana Byndloss receives FASEB Excellence in Science Award
The annual awards highlight outstanding achievements by women in the biological sciences. -
April 2, 2024
VUMC research staff honored for excellence in the lab, clinic
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony. -
March 29, 2024
VUMC’s John Koethe named director of the Tennessee Center for AIDS Research
John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research. -
March 28, 2024
VUMC team discovers antibodies that may prevent severe respiratory illness
Using a technique developed at Vanderbilt University Medical Center, researchers identified antibodies that are excellent leads as potential therapies for human parainfluenza virus 3, a leading cause of acute and potentially fatal respiratory illness.